However, this risk has not been demonstrated in humans at therapeutic doses, and the warning is being reevaluated based on post-marketing surveillance data
Its a paradigm shift that were thinking of obesity not as a failure on the patients part to control their habits, but more of a chronic disease, and treating it like any other chronic disease such as diabetes or high blood pressure, arthritis, or other diseases that people readily will say is not the patients fault, Dr
What happened to common sense
This has the additional advantage of reducing body weight by reducing percentage fat in the body
The medication improved not only weight outcomes but also cardiovascular markers and insulin resistance
Nevertheless, our findings in erythrocytes and previously published in SCD cardiac tissues 46 support that, in addition to inflammation suppression 23 and fetal globin induction 31,63,64 , DMF displays anti-oxidative and ferroptosis stress effects to alleviate SCD clinical severity, and therefore, might be pursued as a new treatment option